Company news
NeoGenomics, Inc. news in 2021
NeoGenomics, Inc.'s news releases, calls and decks from 2021, newest first.
NeoGenomics Appoints David Eberhard MD, PhD as Chief Medical Officer of Inivata Liquid Biopsy Subsidiary
December 12, 2021
NeoGenomics to Leverage Thermo Fisher Scientific’s Ion Torrent Genexus System in Upcoming Phase 1 Study for Myeloid Cancers
December 9, 2021
NeoGenomics To Participate In The Stephens Annual Investment Conference 2021
November 29, 2021
NeoGenomics Appoints Dave Daly to Its Board of Directors
November 9, 2021
NeoGenomics Reports Revenue of $121 Million in the Third Quarter
November 3, 2021
NeoGenomics Announces Leadership Team Transition
November 3, 2021
NeoGenomics' Liquid Biopsy Subsidiary Inivata Announces Clinical Collaboration With Princess Margaret Cancer Center for the Use of Its Liquid Biopsy Assays
October 18, 2021
NeoGenomics Schedules its Third Quarter 2021, Earnings Release for November 4, 2021
October 12, 2021
NeoGenomics Announces Board of Directors' Transition
October 11, 2021
NeoGenomics' Liquid Biopsy Subsidiary Inivata and Collaborators to Present Data that Further Validate the Application of its RaDaR(TM) MRD and InVisionFirst(R)-Lung Assays at the ESMO Congress 2021
September 8, 2021
NeoGenomics to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference
August 31, 2021
NeoGenomics Reports 40% Revenue Growth to $122 Million in the Second Quarter
August 5, 2021
NeoGenomics Schedules its Second Quarter 2021 Earnings Release for August 6, 2021
July 13, 2021
NeoGenomics Completes Inivata Acquisition - Combining Best-In-Class Liquid Biopsy Technology with Leading Community Oncology Platform
June 17, 2021
NeoGenomics To Participate Virtually In Multiple Upcoming Institutional Investor Conferences
May 26, 2021
NeoGenomics To Participate In The Bank of America 2021 Health Care Conference
May 9, 2021
NeoGenomics to Acquire Inivata - Combining Best-In-Class Liquid Biopsy Technology with Leading Community Oncology Platform
May 4, 2021
NeoGenomics Reports 9% Revenue Growth to $116 Million in the First Quarter
May 4, 2021
NeoGenomics Announces the Launch of Biomarker Assist KRAS Single Gene Testing (SGT) Program for Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer Patients
April 18, 2021
NeoGenomics to Participate in the 20th Annual Needham Virtual Healthcare Conference
April 12, 2021
NeoGenomics Schedules its First Quarter 2021 Earnings Release for May 5, 2021
April 6, 2021
NeoGenomics Agrees to Acquire Trapelo Health
March 23, 2021
NeoGenomics and Elevation Oncology Announce Collaboration to Expand Genomic Testing for NRG1 Fusions Across Solid Tumors in Support of the Phase 2 CRESTONE Study
March 15, 2021
Elevation Oncology and NeoGenomics Announce Collaboration to Expand Genomic Testing for NRG1 Fusions Across Solid Tumors in Support of the Phase 2 CRESTONE Study
March 15, 2021
NeoGenomics To Participate In The Virtual Raymond James 42nd Annual Institutional Investors Conference
February 28, 2021
NeoGenomics To Participate In The Virtual 10th Annual SVB Leerink Global Healthcare Conference
February 24, 2021
NeoGenomics Reports 18% Revenue Growth to $126 Million in the Fourth Quarter
February 23, 2021
NeoGenomics Announces CEO Succession
February 23, 2021
NeoGenomics to Participate in the BTIG Virtual Medtech, Digital Health, Life Science & Diagnostic Tools Conference
February 15, 2021
NeoGenomics Schedules its Fourth Quarter and Full Year 2020 Earnings Release for February 24, 2021
February 4, 2021
Parexel and NeoGenomics Announce Strategic Collaboration in Precision Medicine to Improve Study Designs and Accelerate Patient Matching in Oncology Clinical Trials
February 3, 2021
NeoGenomics Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes
January 5, 2021
NeoGenomics Announces Proposed Public Offerings of Common Stock and Convertible Senior Notes
January 4, 2021
NeoGenomics To Virtually Participate In The 39th Annual J.P. Morgan Healthcare Conference
January 3, 2021
Calls in 2021
Decks in 2021
- Investor Presentation (August 2021)
Investor deck · 37 slides · Aug 10, 2021
- Investor Presentation (May 2021)
Investor deck · 35 slides · May 6, 2021